Ex parte BEEBE - Page 3




                 Appeal No. 99-0209                                                                                                                     
                 Application No. 08/643,048                                                                                                             


                 § 103 as being unpatentable over Amos in view of Bayer.2                                                                               
                          The rejection is explained in the Examiner's Answer.                                                                          


                                                                     OPINION                                                                            
                          Rather than reiterate the opposing viewpoints of the                                                                          
                 examiner and the appellant, we refer to the Examiner’s Answer                                                                          
                 (Paper No. 17) and the appellant’s Briefs (Papers Nos. 16 and                                                                          
                 19) for a full explanation thereof.                                                                                                    
                          The test for obviousness is what the combined teachings                                                                       
                 of the prior art would have suggested to one of ordinary skill                                                                         
                 in the art.  See, for example, In re Keller, 642 F.2d 413,                                                                             
                 425, 208 USPQ 871, 881 (CCPA 1981).  In establishing a prima                                                                           
                 facie case of obviousness, it is incumbent upon the examiner                                                                           
                 to provide a reason why one of ordinary skill in the art would                                                                         
                 have been led to modify a prior art reference or to combine                                                                            

                          2Although not so designated, technically, this is a new                                                                       
                 rejection made for the first time in the Examiner’s Answer, in                                                                         
                 that it is applied for the first time against a number of the                                                                          
                 claims.  In the final rejection, the examiner rejected claims                                                                          
                 1-4, 8-12 and 16 under 35 U.S.C. § 102(b) as being anticipated                                                                         
                 by Amos, and claims 5, 7, 13 and 15 under 35 U.S.C. § 103 as                                                                           
                 being unpatentable over Amos in view of Bayer.  The Section                                                                            
                 102 rejection has been withdrawn, and the appellant has                                                                                
                 responded to the new Section 103 rejection in the Reply Brief.                                                                         

                                                                           3                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007